| 25.58 0.87 (3.52%) | 09-11 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 39.55 |
1-year : | 46.72 |
| Resists | First : | 33.86 |
Second : | 40 |
| Pivot price | 25.61 |
|||
| Supports | First : | 23.95 |
Second : | 19.92 |
| MAs | MA(5) : | 25.04 |
MA(20) : | 25.5 |
| MA(100) : | 22.75 |
MA(250) : | 35.79 |
|
| MACD | MACD : | 0.4 |
Signal : | 0.7 |
| %K %D | K(14,3) : | 25.9 |
D(3) : | 20.9 |
| RSI | RSI(14): 53.6 |
|||
| 52-week | High : | 76.51 | Low : | 17.14 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ DOCS ] has closed above bottom band by 49.2%. Bollinger Bands are 24.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 25.77 - 25.9 | 25.9 - 26.01 |
| Low: | 24.4 - 24.54 | 24.54 - 24.67 |
| Close: | 25.34 - 25.58 | 25.58 - 25.79 |
Doximity, Inc. provides a digital platform, hosted in the cloud, specifically designed for healthcare practitioners throughout the United States. This platform delivers a suite of specialized tools, empowering its members to connect with peers, streamline patient treatment, conduct remote consultations, access current medical information and research, and advance their professional careers. Its primary clientele consists of pharmaceutical companies and healthcare organizations. Established in 2010, the entity initially operated as 3MD Communications, Inc. before rebranding to Doximity, Inc. in June of that year. The company's corporate headquarters are situated in San Francisco, California.
Sat, 12 Sep 2026
Engineers Gate Manager LP Increases Stock Position in Doximity, Inc. $DOCS - MarketBeat
Fri, 11 Sep 2026
Doximity Inc (DOCS) Stock Up 3.5% and Still Undervalued -- GF Sc - GuruFocus
Thu, 10 Sep 2026
Precision Trading with Doximity Inc. Class A (DOCS) Risk Zones - Stock Traders Daily
Tue, 08 Sep 2026
Doximity, Inc. $DOCS Shares Sold by Carmignac Gestion - MarketBeat
Tue, 08 Sep 2026
Doximity stock downgraded at Freedom Capital (DOCS:NYSE) - Seeking Alpha
Mon, 07 Sep 2026
Doximity, Inc. (DOCS) Stock Analysis: Navigating a 13% Potential Upside Amidst Healthcare Innovation - DirectorsTalk Interviews
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 127 (M) |
| Shares Float | 124 (M) |
| Held by Insiders | 2.8 (%) |
| Held by Institutions | 102.8 (%) |
| Shares Short | 18,430 (K) |
| Shares Short P.Month | 20,730 (K) |
| EPS | 0.83 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 5.09 |
| Profit Margin | 25.4 % |
| Operating Margin | 21.5 % |
| Return on Assets (ttm) | 10.9 % |
| Return on Equity (ttm) | 17.2 % |
| Qtrly Rev. Growth | 7.3 % |
| Gross Profit (p.s.) | 4.53 |
| Sales Per Share | 5.14 |
| EBITDA (p.s.) | 1.63 |
| Qtrly Earnings Growth | -52 % |
| Operating Cash Flow | 306 (M) |
| Levered Free Cash Flow | 240 (M) |
| PE Ratio | 30.45 |
| PEG Ratio | 0.5 |
| Price to Book value | 5.02 |
| Price to Sales | 4.96 |
| Price to Cash Flow | 10.63 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|